A case of response to combination treatment with TSA-DC-CTL immunotherapy and osimertinib in EGFR mutated advanced lung adenocarcinoma

Abstract Background This study details a case of a patient with advanced lung adenocarcinoma harboring an exon 19 deletion in the EGFR gene. Method A 46-year-old female patient was diagnosed with stage IVb left lung adenocarcinoma, with multiple bone and lymph node metastases. Following the identifi...

Full description

Bibliographic Details

Published in:	Molecular Cancer
Main Authors:	Zhiyi Han, Tao Li, Heng Zhang, Kai Liang, Mingcong You, Mengdi Xu, Fan Bai, Tongmei Zhang
Format:	Article
Language:	English
Published:	BMC 2024-08-01
Subjects:	Cellular immunotherapy TSA-DC-CTL EGFR gene mutation Advanced lung cancer
Online Access:	https://doi.org/10.1186/s12943-024-02070-3